Mold-Tek Packaging Reports Robust Q1 Results with 22% Revenue Growth and Expanding Pharma Business
Mold-Tek Packaging Limited reported robust Q1 financial results, with revenue growing 22% year-over-year and net profit increasing by 35%. The company saw improvements across all segments, with the paint segment, supported by Aditya Birla Grasim, being a significant growth driver. The pharma segment achieved breakeven and grew 11% compared to Q4. Despite early monsoons affecting the Food & FMCG segment, it still recorded 16% growth. The company processed a total of 11,400 tons across all segments and saw per kg sales revenue increase from INR 198.00 to INR 211.00. Mold-Tek is expanding its operations, with new production starting in Panipat and additional investments planned for pharma capacity.

*this image is generated using AI for illustrative purposes only.
Mold-Tek Packaging Limited , a leading manufacturer of plastic packaging solutions, has reported strong financial results for the first quarter, demonstrating significant growth across key metrics and segments.
Financial Highlights
- Revenue grew by 22% year-over-year
- EBITDA margin improved to 19.70% from 18.00% in the previous year
- Net profit increased by 35%
- EBITDA per kg grew by 29%
Segment Performance
Paint Segment
The paint segment emerged as a significant driver of growth, primarily supported by Aditya Birla Grasim (ABG). The company processed 5,600 tons in this segment during the quarter.
Pharma Segment
The pharma segment achieved breakeven and grew 11% compared to Q4. The company processed 190 tons in this segment and is targeting revenue of INR 35.00 crores for the current financial year, up from INR 8.00-9.00 crores last year.
Food & FMCG Segment
Despite early monsoons affecting ice cream and yogurt consumption, the Food & FMCG segment recorded 16% growth. The company processed 3,200 tons in this segment.
Lubricants Segment
The company processed 2,400 tons in the lubricants segment.
Operational Metrics
Metric | Value |
---|---|
Total processing volume across segments | 11,400 tons |
Per kg sales revenue | Increased from INR 198.00 to INR 211.00 |
Expansion Plans
- Panipat thin wall food production is set to start in August
- Additional pharma capacity investments of INR 80.00-90.00 crores are planned
- The company expects overall volume of 43,000-45,000 tons for the full year with 12-15% value growth
Pharma Business Expansion
Multiple pharma companies, including Laurus Labs and Pulse, have approved Mold-Tek's facilities and started commercial orders. The company is expanding its pharma capacity and product range to meet growing demand.
Management Commentary
J. Lakshmana Rao, Chairman and Managing Director of Mold-Tek Packaging Limited, commented on the results during the earnings conference call: "We are very happy to inform you of an excellent performance in this quarter by Mold-Tek Packaging, where the revenues have shot up by 22%, and EBITDA margin has also shot up from 18-odd percentage last year to 19.7%. This growth was possible due to all the sectors doing very well this year."
Rao also highlighted the company's progress in the pharma segment, stating, "What is more exciting for us at Mold-Tek is the speed at which the Pharma packaging is getting adopted and approved by several major players in the pharma industry."
Future Outlook
The company remains optimistic about its growth prospects, particularly in the pharma and Food & FMCG segments. With ongoing capacity expansions and new product developments, Mold-Tek Packaging is well-positioned to capitalize on emerging opportunities in the packaging industry.
As the company continues to focus on innovation and efficiency, investors and industry observers will be watching closely to see how Mold-Tek Packaging builds on its strong start to the fiscal year.
Historical Stock Returns for Mold-Tek Packaging
1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|
-0.44% | -1.79% | +3.52% | +89.16% | +1.21% | +180.81% |